The pathogenesis and natural history of type 1 diabetes

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 11, 2012, Pages

  Atkinson, Mark A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD45 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; AUTOIMMUNITY; CELL DAMAGE; CELL DESTRUCTION; CELL PROLIFERATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE INTOLERANCE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PREVALENCE; REGULATORY T LYMPHOCYTE; VARIABLE NUMBER OF TANDEM REPEAT; CELLULAR IMMUNITY; DIET; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; REVIEW; VIRUS INFECTION;

AUTOANTIBODIES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DIET; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, CELLULAR; VIRUS DISEASES;

EID: 84868551420     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007641     Document Type: Article

References (123)

1. Adler K, Mueller DB, Achenbach P, Krause S, Heninger AK, Ziegler AG, BonifacioE. 2011. Insulin autoantibodies with high affinity to the bovine milk protein α casein. Clin Exp Immunol 164: 42-49.
2. Akirav E, Kushner JA, Herold KC. 2008. β-Cell mass and type 1 diabetes: Going, going, gone? Diabetes 57: 2883-2888.
3. Alberti KG, Zimmet PZ. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
4. American Diabetes Association. 2010. Diagnosis and classification of diabetes mellitus. Diabetes Care 33: S62-S69.
5. Atkinson MA. 2005. ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: Why can't we prevent or reverse this disease? Diabetes 54: 1253-1263.
6. Atkinson MA, Eisenbarth GS. 2001. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 358: 221-229.
7. Atkinson M, Gale EA. 2003. Infant diets and type 1 diabetes: Too early, too late, or just too complicated? JAMA 290: 1771-1772.
8. Atkinson MA, Gianani R. 2009. The pancreas in human type 1 diabetes: Providing new answers to age-old questions. Curr Opin Endocrinol Diabetes Obes 16: 279-285.
9. Atkinson MA, Bowman MA, Kao KJ, Campbell L, Dush PJ, Shah SC, Simell O, Maclaren NK. 1993. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 329: 1853-1858.
10. Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Pietropaolo M, Arvan PR, Von Herrath M, Markel DS, et al. 2011. How does type 1 diabetes develop? The notion of homicide or β-cell suicide revisited. Diabetes 60: 1370-1379.
11. Bach JF. 2005. Six questions about the hygiene hypothesis. Cell Immunol 233: 158-161.
12. Bailey R, Cooper JD, Zeitels L, Smyth DJ, Yang JH, Walker NM, Hyppönen E, Dunger DB, Ramos-Lopez E, Badenhoop K, et al. 2007. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56: 2616-2621.
13. Berhan Y, Waernbaum I, Lind T, Möllsten A, Dahlquist G, Swedish Childhood Diabetes Study Group. 2011. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: The accelerating increase by time tends to level off in Sweden. Diabetes 60: 577-581.
14. Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M. 2009. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 32: 1977-1979.
15. Bingley PJ. 2010. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 95: 25-33.
16. Blom L, Dahlquist G, Nystrom L, Sandstrom A, Wall S. 1989. The Swedish childhood diabetes study-Social and perinatal determinants for diabetes in childhood. Diabetologia 32: 7-13.
17. Bluestone JA, Herold K, Eisenbarth G. 2010. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464: 1293-1300.
18. Boettler T, von Herrath M. 2011. Protection against or triggering of Type 1 diabetes? Different roles for viral infections. Expert Rev Clin Immunol 7: 45-53.
19. Bonifacio E, Ziegler AG. 2010. Advances in the prediction and natural history of type 1 diabetes. Endocrinol Metab Clin North Am 39: 513-525.
20. Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J. 1984. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis. Lancet 2: 1083-1086.
21. Clynes R. 2010. B cell therapy is β-tested: Rituximab puts a pause on β-cell destruction. Islets 2: 130-132.
22. Concannon P, Rich SS, Nepom GT. 2009. Genetics of type 1A diabetes. N Engl J Med 360: 1646-1654.
23. Cooke A. 2009. Review series on helminths, immune modulation and the hygiene hypothesis: How might infection modulate the onset of type 1 diabetes?Immunology 126: 12-17.
24. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, Downes K, Barrett JC, Healy BC, Mychaleckyj JC, et al. 2008. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 40: 1399-1401.
25. Dabelea D, Bell RA, D'Agostino RB, Imperatore G, Johansen JM, Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, et al. 2007. Incidence of diabetes in youth in the United States. JAMA 297: 2716-2724.
26. Dabelea D, Pihoker C, Talton JW, D'Agostino RB, Fujimoto W, Klingensmith GJ, Lawrence JM, Linder B, Marcovina SM, Mayer-Davis EJ, et al. 2011. Etiological approach to characterization of diabetes type: The SEARCH for Diabetes in Youth Study. Diabetes Care 34: 1628-1633.
27. Dahlquist G. 2006. Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis. Diabetologia 49: 20-24.
28. Dahlquist GG, Patterson C, Soltesz G. 1999. Perinatal risk factors for childhood type 1 diabetes in Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22: 1698-1702.
29. DIAMOND Project Group. 2006. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 23: 857-866.
30. Eisenbarth GS. 1986. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314: 1360-1368.
31. Eisenbarth GS. 2007. Update in Type 1 Diabetes. J Clin Endocrinol Metab 92: 2403-2407.
32. EURODIAB ACE Study Group. 2000. Variation and trends in incidence of childhood diabetes in Europe. Lancet 355: 873-876.
33. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. 1997. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197.
34. Flood TM, Brink SJ, Gleason RE. 1982. Increased incidence of type I diabetes in children of older mothers. Diabetes Care 5: 571-573.
35. Foulis AK. 2008. Pancreatic pathology in type 1 diabetes in human. Novartis Found Symp 292: 2-13.
36. Fourlanos S, Harrison LC, Colman PG. 2008. The accelerator hypothesis and increasing incidence of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 15: 321-325.
37. Gale EA. 2002a. A missing link in the hygiene hypothesis? Diabetologia 45: 588-594.
38. Gale EA. 2002b. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51: 3353-3361.
39. Gale EA. 2005. Type 1 diabetes in the young: The harvest of sorrow goes on. Diabetologia 48: 1435-1438.
40. Gale EA. 2008. Congenital rubella: Citation virus or viral cause of type 1 diabetes? Diabetologia 51: 1559-1566.
41. Gerstein HC. 1994. Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature. Diabetes Care 17: 13-19.
42. Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, Gale EA. 2004. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364: 1699-1700.
43. Hämäläinen AM, Knip M. 2002. Autoimmunity and familial risk of type 1 diabetes. Curr Diab Rep 2: 347-353.
44. Harjutsalo V, Sjöberg L, Tuomilehto J. 2008. Time trends in the incidence of type 1 diabetes in Finnish children: A cohort study. Lancet 371: 1777-1782.
45. Hermann R, Knip M, Veijola R, Simell O, Laine AP, Akerblom HK, Groop PH, Forsblom C, Pettersson-Fernholm K, Ilonen J, et al. 2003. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-Indication of an increased environmental pressure? Diabetologia 46: 420-425.
46. Hober D, Sauter P. 2010. Pathogenesis of type 1 diabetes mellitus: Interplay between enterovirus and host. Nat Rev Endocrinol 6: 279-289.
47. Holt PG, James CA. 2000. The development of the immune system during pregnancy and early life. Allergy 55: 688-697.
48. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y, Osaka IDDM Study Group. 2000. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 342: 301-307.
49. In't Veld P. 2011. Insulitis in human type 1 diabetes: The quest for an elusive lesion. Islets 3: 131-138.
50. In't Veld P, Lievens D, De Grijse J, Ling Z, Van der Auwera B, Pipeleers-MarichalM, Gorus F, Pipeleers D. 2007. Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56: 2400-2404.
51. Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. 2010. Enteroviruses and type 1 diabetes: Towards a better understanding of the relationship. Rev Med Virol 20: 265-280.
52. Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson BH, Savilahti E, AkerblomHK, Dosch HM. 1992. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 327: 302-307.
53. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, TuomilehtoJ. 2000. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23: 1516-1526.
54. Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Akerblom HK. 2005. Environmental triggers and determinants of type 1 diabetes. Diabetes 54: S125-S136.
55. Knip M, Virtanen SM, Seppä K, Ilonen J, Savilahti E, Vaarala O, Reunanen A, Teramo K, Hämäläinen AM, Paronen J, et al. 2010a. Dietary intervention in infancy and later signs of β-cell autoimmunity. N Engl J Med 363: 1900-1908.
56. Knip M, Korhonen S, Kulmala P, Veijola R, Reunanen A, Raitakari OT, Viikari J, Akerblom HK. 2010b. Prediction of type 1 diabetes in the general population. Diabetes Care 33: 1206-1212.
57. Kostraba JN, Gay EC, Cai Y, Cruickshanks KJ, Rewers MJ, Klingensmith GJ, Chase HP, Hamman RF. 1992a. Incidence of insulin-dependent diabetes mellitus in Colorado. Epidemiology 3: 232-238.
58. Kostraba JN, Gay EC, Rewers M, Hamman RF. 1992b. Nitrate levels in community drinking waters and risk of IDDM. An ecological analysis. Diabetes Care 15: 1505-1508.
59. Krischer JP, Cuthbertson DD, Greenbaum C. 2004. Male sex increases the risk of autoimmunity but not type 1 diabetes. Diabetes Care 27: 1985-1990.
60. Kukko M, Kimpimäki T, Korhonen S, Kupila A, Simell S, Veijola R, Simell T, Ilonen J, Simell O, Knip M. 2005. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 90: 2712-2717.
61. Kukreja A, Maclaren NK. 2002. NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates. Diabetes Technol Ther 4: 323-333.
62. La Torre D, Lernmark A. 2010. Immunology of β-cell destruction. Adv Exp Med Biol 654: 537-583.
63. Lefebvre DE, Powell KL, Strom A, Scott FW. 2006. Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 26: 175-202.
64. Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, YderstraedeK, Sarti C, Thivolet C, Hadden D, et al. 2008. Diabetes classification: Grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 24: 511-519.
65. Libman IM, LaPorte RE, Becker D, Dorman JS, Drash AL, Kuller L. 1998. Was there an epidemic of diabetes in nonwhite adolescents in Allegheny County, Pennsylvania? Diabetes Care 21: 1278-1281.
66. Littorin B, Blom P, Schölin A, Arnqvist HJ, Blohmé G, Bolinder J, Ekbom-SchnellA, Eriksson JW, Gudbjörnsdottir S, Nyström L, et al. 2006. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: Results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49: 2847-2852.
67. Luopajärvi K, Savilahti E, Virtanen SM, Ilonen J, Knip M, Akerblom HK, VaaralaO. 2008. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr Diabetes 9: 434-441.
68. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. 2010. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39: 481-497.
69. + T cells. Blood 106: 2798-2805.
70. Mariño E, Silveira PA, Stolp J, Grey ST. 2011. B cell-directed therapies in type 1 diabetes. Trends Immunol 32: 287-294.
71. Matveyenko AV, Butler PC. 2008. Relationship between β-cell mass and diabetes onset. Diabetes Obes Metab 10: 23-31.
72. McKinney PA, Parslow R, Gurney K, Law G, Bodansky HJ, Williams DR. 1997. Antenatal risk factors for childhood diabetes mellitus; a case-control study of medical record data in Yorkshire, UK. Diabetologia 40: 933-939.
73. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC. 2005. Sustained β cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration? Diabetologia 48: 2221-2228.
74. Miao D, Yu L, Eisenbarth GS. 2007. Role of autoantibodies in type 1 diabetes. Front Biosci 12: 1889-1898.
75. Moltchanova EV, Schreier N, Lammi N, Karvonen M. 2009. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabet Med 26: 673-678.
76. Nerup J, Mandrap-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T. 1994. On the pathogenesis of IDDM. Diabetologia 37: S82-S89.
77. Nierras CR, Atkinson MA, Goldstein RA. 2010. The Juvenile Diabetes Research Foundation at forty: Updates of research in type 1 diabetes. Diabetes 59: 1575-1577.
78. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, et al. 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5: 1075-1080.
79. Noble JA, Erlich HA. 2012. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med 2: a007732.
80. Norris JM, Beaty B, Klingensmith G, Yu L, Hoffman M, Chase HP, Erlich HA, Hamman RF, Eisenbarth GS, Rewers M. 1996. Lack of association between early exposure to cow's milk protein and β-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY). JAMA 276: 609-614.
81. Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M. 2003. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290: 1713-1720.
82. Oikarinen M, Tauriainen S, Honkanen T, Vuori K, Karhunen P, Vasama-Nolvi C, Oikarinen S, Verbeke C, Blair GE, Rantala I, et al. 2008. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 51: 1796-1802.
83. Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, Yu L, Palmer JP, Schatz D, Eisenbarth G. 2009. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Prevention Trial-Type 1 Study Group. Diabetes Care 32: 2269-2274.
84. Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM. 2005. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 54: 62-67.
85. Patterson CC, Carson DJ, Hadden DR, Waugh NR, Cole SK. 1994. A case-control investigation of perinatal risk factors for childhood IDDM in Northern Ireland and Scotland. Diabetes Care 17: 376-381.
86. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G, EURODIAB Study Group. 2009. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet 373: 2027-2033.
87. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, et al. 2009. Rituximab, B-lymphocyte depletion, and preservation of β-cell function. Type 1 Diabetes Trial Net Anti-CD20 Study Group. N Engl J Med 361: 2143-2152.
88. Pociot F, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, Nierras CR, Todd JA, Rich SS, Nerup J. 2010. Genetics of type 1 diabetes: What's next?Diabetes 59: 1561-1571.
89. 3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res 37: 680-683.
90. Pugliese A, Zeller M, Fernandez A Jr., Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15: 293-297.
91. Redondo MJ, Fain PR, Eisenbarth GS. 2001. Genetics of type 1A diabetes. Recent Prog Horm Res 56: 69-89.
92. Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T. 2008. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med 359: 2849-2850.
93. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. 2009. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52: 1143-1151.
94. Roep BO. 2003. The role of T-cells in the pathogenesis of type 1 diabetes: From cause to cure. Diabetologia 46: 305-321.
95. Rolandsson O, Palmer JP. 2010. Latent autoimmune diabetes in adults (LADA) is dead: Long live autoimmune diabetes! Diabetologia 53: 1250-1253.
96. Schatz D, Krischer J, Horne G, Riley W, Spillar R, Silverstein J, Winter W, Muir A, Derovanesian D, Shah S. 1994. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 93: 2403-2407.
97. Skyler JS. 2007. Prediction and prevention of type 1 diabetes: Progress, problems, and prospects. Clin Pharmacol Ther 81: 768-771.
98. Skyler JS, Ricordi C. 2011. Stopping type 1 diabetes: Attempts to prevent or cure type 1 diabetes in man. Diabetes 60: 1-8.
99. Soltesz G, Patterson CC, Dahlquist G. 2007. Worldwide childhood type 1 diabetes incidence-What can we learn from epidemiology? Pediatr Diabetes 8: 6-14.
100. Sosenko JM, Skyler JS, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Cuthbertson D, Cowie C, Herold K, Eisenbarth G, et al. 2010. Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1). Diabetes 59: 2386-2389.
101. Steck AK, Armstrong TK, Babu SR, Eisenbarth GS. 2011. Type 1 Diabetes Genetics Consortium. Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years. Diabetes 60: 1045-1049.
102. Svoren BM, Volkening LK, Wood JR, Laffel LM. 2009. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr 154: 132-134.
103. Taplin CE, Barker JM. 2008. Autoantibodies in type 1 diabetes. Autoimmunity 41: 11-18.
104. Tattersall RB, Pyke DA. 1972. Diabetes in identical twins. Lancet 2: 1120-1125.
105. Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. 2011. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 33: 45-55.
106. Thunandera M, Petersson C, Jonzon K, Fornander J, Ossiansson B, Torn C, Edvardsson S, Landin-Olsson M. 2008. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 82: 247-255.
107. Todd JA. 1991. A protective role of the environment in the development of type 1 diabetes? Diabet Med 8: 906-910.
108. Todd JA. 2010. Etiology of type 1 diabetes. Immunity 32: 457-467.
109. Torii S. 2009. Expression and function of IA-2 family proteins, unique neuroendocrine-specific protein-tyrosine phosphatases. Endocr J 56: 639-648.
110. TRIGR Study Group, Akerblom HK, Krischer J, Virtanen SM, Berseth C, Becker D, Dupré J, Ilonen J, Trucco M, Savilahti E, et al. 2011. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: Recruitment, intervention and follow-up. Diabetologia 54: 627-33.
111. Tsirogianni A, Pipi E, Soufleros K. 2009. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. Autoimmun Rev 8: 687-691.
112. Vaarala O. 2005. Is type 1 diabetes a disease of the gut immune system triggered by cow's milk insulin? Adv Exp Med Biol 569: 151-156.
113. Vaarala O, Atkinson MA, Neu J. 2008. The "perfect storm" for type 1 diabetes: The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57: 2555-2562.
114. Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK. 1997. Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry. Diabetes Care 20: 1556-1561.
115. von Herrath MG, Fujinami RS, Whitton JL. 2003. Microorganisms and autoimmunity: Making the barren field fertile? Nat Rev Microbiol 1: 151-157.
116. von Herrath M, Sanda S, Herold K. 2007. Type 1 diabetes as a relapsing-remitting disease? Nat Rev Immunol 7: 988-994.
117. Wasserfall C, Nead K, Mathews C, Atkinson MA. 2011. The Threshold Hypothesis. Solving the equation of nurture versus nature in type 1 diabetes. Diabetologia 54: 2232-2236.
118. Weets I, Van Autreve J, Van der Auwera BJ, Schuit FC, Du Caju MV, Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, et al. 2001. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index. Diabetologia 44: 40-47.
119. Wilkin TJ. 2001. The accelerator hypothesis: Weight gain as the missing link between Type I and Type II diabetes. Diabetologia 44: 914-922.
120. Winter WE, Schatz DA. 2011. Autoimmune markers in diabetes. Clin Chem 57: 168-175.
121. Zhang L, Nakayama M, Eisenbarth GS. 2008. Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol 20: 111-118.
122. Ziegler AG, Nepom GT. 2010. Prediction and pathogenesis in type 1 diabetes. Immunity 32: 468-478.
123. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. 2003. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA290: 1721-1728.